Animate Biosciences

Executive Summary

Animate Biosciences is an early-stage private biotech company founded in 2021 and headquartered in San Diego, CA. The company is pioneering AI-powered regenerative science to address pathological tissue remodeling, a process that underlies nearly half of all global deaths by damaging tissues across major organs. Current treatments are palliative and organ-specific, leaving a significant unmet need for therapies that can reverse or halt tissue damage. Animate leverages artificial intelligence to discover and develop novel regenerative medicines that aim to restore tissue function and extend both lifespan and healthspan. The company is currently in Phase 1 development, with a focus on building its platform and advancing lead programs toward clinical validation. While specific financial details and pipeline assets are not publicly disclosed, Animate's approach targets a broad and devastating disease mechanism, positioning it as a potential leader in regenerative medicine. The company's success hinges on demonstrating preclinical proof-of-concept and securing additional funding to advance its programs into the clinic.

Upcoming Catalysts (preview)

• Q4 2026Preclinical proof-of-concept data for lead program40% success
• H1 2027Series A financing round60% success
• Q2 2026Research collaboration or licensing agreement35% success